• Thu, January 23, 2025

by: MSN

Avidity Biosciences CFO sells $93,985 in stock

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

by: AOL

Warren Buffett: 5 Stocks He's Dead Serious About In 2025

Warren Buffett, the legendary investor known as the "Oracle of Omaha," continues to make waves in the financial world even as he approaches his mid-90s. His company, Berkshire Hathaway, has been

by: WOPRAI

Short squeeze is starting in shares of EVLV at $3.91, after crossing above the $3.897 Trigger Price

by: Forbes

S&P 500 Index Funds: Risks You Must Know Before You Invest

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: MSN

2 'Strong Buy'-Rated Dividend Stocks With Yields Above 7% for 2025

Investing in dividend stocks with a high yield of more than 7% can significantly boost your portfolio's income potential, especially in a low-interest-rate environment. However, targeting companies with sustainable dividend payouts is crucial,

by: Forbes

Is Quantum Computing Investable As The Next AI

Quantum computing has the potential of being the next big innovation. At the right size and the right price, it might even be investable.

by: WOPRAI

Short squeeze is starting in shares of NUVI at $0.022, after crossing above the $0.02 Trigger Price

by: MSN

Altimmune's SWOT analysis: pemvidutide potential drives stock outlook

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention from analysts and investors alike.

by: MSN

Diamondback Energy's SWOT analysis: stock poised for growth amid merger synergies

Diamondback Energy Inc (NASDAQ:FANG), a leading independent oil and gas company focused on the Permian Basin with a market capitalization of $51.48 billion, has been making significant strides in operational efficiency and strategic growth.

by: MSN

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposé led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

by: MSN

Is AbbVie Inc. (ABBV) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other halal dividend stocks.

by: MSN

Is Intel Corporation (INTC) One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other best socially responsible stocks to buy according to hedge funds.

by: MSN

Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other halal dividend stocks.

by: MSN

BlackRock CEO Fink advocates for tokenization of stocks and bonds

In a recent public statement, Larry Fink, the Chief Executive Officer of BlackRock (NYSE:BLK), expressed his support for the Securities and Exchange Commission (SEC) to approve the tokenization of bonds and stocks.

by: MSN

Is PepsiCo, Inc. (PEP) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where PepsiCo, Inc. (NASDAQ:PEP) stands against the other halal dividend stocks.
  • Fri, January 24, 2025

by: WOPRAI

Wood Lay Maintained (CWBC) at Market with Decreased Target to $22 on, Jan 24th, 2025

by: WOPRAI

Matt Breese Reiterated (CUBI) at Equal and Held Target at $58 on, Jan 24th, 2025

by: WOPRAI

Patrick Brown Reiterated (CSX) at Outperform with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

James McGarragle Maintained (CSX) at Sector with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Brian Ossenbeck Maintained (CSX) at Overweight with Decreased Target to $37 on, Jan 24th, 2025

by: WOPRAI

Brandon Oglenski Maintained (CSX) at Overweight with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Benjamin Hartford Maintained (CSX) at Outperform with Decreased Target to $38 on, Jan 24th, 2025

by: WOPRAI

Ariel Rosa Maintained (CSX) at Buy with Decreased Target to $39 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (CR) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (CPT) at Overweight with Decreased Target to $126 on, Jan 24th, 2025

by: WOPRAI

Lisa Gill Maintained (COR) at Overweight with Increased Target to $301 on, Jan 24th, 2025

by: WOPRAI

Christopher Mcgratty Maintained (COLB) at Market with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Patrick Scholes Maintained (CCL) at Hold with Increased Target to $30 on, Jan 24th, 2025

by: WOPRAI

Lisa Gill Maintained (CAH) at Neutral with Increased Target to $142 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (CAG) at Hold with Decreased Target to $28 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (MAA) at Equal with Decreased Target to $152 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Upgraded (MAA) to Overweight and Increased Target to $168 on, Jan 24th, 2025

by: WOPRAI

Arvind Ramnani Maintained (MA) at Overweight with Increased Target to $591 on, Jan 24th, 2025

by: WOPRAI

Paul Lejuez Reinstated (KR) to Neutral and Held Target at $61 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (KHC) at Hold with Decreased Target to $32 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITW) at Hold with Decreased Target to $266 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITT) at Buy with Decreased Target to $179 on, Jan 24th, 2025

by: WOPRAI

Richard Newitter Maintained (ISRG) at Buy with Increased Target to $666 on, Jan 24th, 2025

by: WOPRAI

Joanne Wuensch Maintained (ISRG) at Buy with Increased Target to $711 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (IRT) at Equal with Decreased Target to $21 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (IR) at Hold with Decreased Target to $100 on, Jan 24th, 2025

by: WOPRAI

Julien Roch Upgraded (IPG) to Overweight and Increased Target to $36 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (INVH) to Equal and Decreased Target to $35 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HSY) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HAIN) at Hold with Decreased Target to $7 on, Jan 24th, 2025

by: WOPRAI

Gil Luria Maintained (GOOGL) at Neutral with Increased Target to $200 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (GIS) at Buy with Decreased Target to $72 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (GE) at Overweight with Increased Target to $250 on, Jan 24th, 2025

Warren Buffett: 5 Stocks He's Dead Serious About In 2025

Warren Buffett, the legendary investor known as the "Oracle of Omaha," continues to make waves in the financial world even as he approaches his mid-90s. His company, Berkshire Hathaway, has been
The article from AOL discusses Warren Buffett's investment strategy, focusing on five stocks he has sold off, indicating his lack of confidence in their future performance. These stocks include Wells Fargo, which Buffett has significantly reduced his stake in due to its involvement in various scandals; IBM, where he has shifted his investments towards newer technology companies; and three other companies not explicitly named in the summary but implied to be part of his portfolio adjustments. The piece highlights Buffett's approach to investing, emphasizing his preference for companies with strong fundamentals and long-term growth potential, and his readiness to divest from those that no longer meet his criteria for investment.

Read the Full AOL Article at:
https://www.aol.com/warren-buffett-5-stocks-dead-120016004.html